Scanvet Polandsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-04-22
Share capital
409 860,00 PLN
Activity description

Scanvet Poland offers technologically advanced dietary supplements for animals based on natural ingredients. Its products support areas including herpesvirus, oral health, skin and coat, joints and bones, stress, the urinary and digestive systems, ears, senior animals and cats.

Registered address
Kiszkowska 9, 62-200 Skiereszewo, Poland
Website
Phone
Social media
Electronic delivery address
AE:PL-96087-58568-IJDRF-28

Financials

Financial statements filed on time (last 5 years). The latest was audited by a statutory auditor.

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 10.08mMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 159.25kMedianUSD 37.20kAverageUSD 879.51k
Operating costs
This companyUSD 9.88mMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 3.31mMedianUSD 608.08kAverageUSD 11.85m

Bank accounts

Registered as a VAT taxpayer on 1993-07-05.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$72,619
Buildings and premises
$162.1K

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$8,356
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$8,387
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$7,980

Trademarks

Scanvet Poland holds 33 active trademarks registered with the Polish Patent Office. 79 marks have expired or were not registered. The first mark was filed in 1992.

MarkProtected until
Vetronix(word)Jan 2, 2036
RELAXER(word)Jan 31, 2029
OptiCeum(word)Dec 6, 2027
SUL-TRIDIN(word)Mar 18, 2035
Scanopril(word)Jan 9, 2035

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Andrzej Matławski – Attorney-in-fact (sole)
Flemming Velin – President of the Management Board
Martin Liberski – Management Board Member
Stanisław Matławski – Attorney-in-fact (sole)

Manner of representation

If the management board is multi-member, declarations of will on behalf of the company require the joint action of two members of the management board or one member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Scanvet A/s
621$110,713.13100%

Beneficial owners

Person

Competitors

Name
EMS - Euromed Medical Solutionsp. z o.o.
MedaseptS.A.
PHS Hospitalsp. z o.o. + limited partnership
Sonomedical Pluciński, Wojciechowski, Wituskisp. j.
Medaidsp. z o.o.
Meditechsp. z o.o.
PNN Pharmaceuticals sp. z o.o.sp. k.
Medicallenssp. z o.o.
Integris Medical Polskasp. z o.o.
Aptekssp. z o.o.

Change history

DateEvent
2003-03-18Name change
2003-02-04Address change
2002-12-10Address change
2002-04-22Entered in the register

FAQ

Last updated: 2026-10-07